PART I . Overview We are a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation, or TPD, science to create a new generation of small-molecule medicines that transform patients lives. Leveraging our proprietary TORPEDO platform, we efficiently design and optimize small molecule protein degraders that are highly active against their desired targets by harnessing the bodys natural process for destroying unwanted proteins. Our strategy is to...
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-012000 | EDGAR | 94K words |
| 2025-02-27 | 2024-12-31 | 0001628280-25-008433 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0001628280-24-006144 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0001628280-23-004711 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006499 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012531 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001628280-26-055494 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001628280-25-049854 | EDGAR | 61K words |
| 2025-08-07 | 2025-06-30 | 0001628280-25-038587 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001628280-25-022866 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0001628280-24-044411 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001628280-24-033882 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001628280-24-021368 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0001628280-23-035793 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001628280-23-027941 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001628280-23-015459 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001628280-22-027985 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001628280-22-020886 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001628280-26-055490 | EDGAR | — |
| 2026-02-26 | 0001628280-26-011971 | EDGAR | 2K words |
| 2026-01-14 | 0001628280-26-002010 | EDGAR | — |
| 2025-11-06 | 0001628280-25-049850 | EDGAR | — |
| 2025-10-16 | 0001193125-25-241591 | EDGAR | — |
| 2025-10-16 | 0001628280-25-045157 | EDGAR | — |
| 2025-10-01 | 0001628280-25-043290 | EDGAR | — |
| 2025-09-22 | 0001628280-25-042245 | EDGAR | — |
| 2025-08-07 | 0001628280-25-038576 | EDGAR | — |
| 2025-06-18 | 0001628280-25-032155 | EDGAR | — |
109 total filings indexed. 81 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001662579 |
| Ticker | CCCC |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.c4therapeutics.com |
| Listed | 2020-10-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CCCC (~200 tokens, structured JSON with cryptographic provenance)